Introduction
Non-invasive testing with single-photon emission computed tomography (SPECT) is frequently used in patients with stable angina. It provides diagnostic and prognostic information improving patient selection for invasive coronary angiography and coronary revascularization. However, there has been concern about underestimation of perfusion defect severity and the possibility of false-negative findings. [1] [2] [3] Importantly, the majority of previous studies that have suggested an impaired sensitivity of SPECT to detect ischaemia have only used invasive coronary angiography as a reference test. [4] [5] [6] It is well known that invasive coronary angiography has a high misclassification rate with invasive functional fractional flow reserve (FFR) measurements. 7, 8 Combining anatomical and functional information may improve the selection of patients who could benefit from coronary revascularization. We assessed the frequency of functionally relevant obstructive coronary disease, defined as coronary stenoses that were both anatomically and functionally relevant in patients referred for invasive FFR measurements because of persistent complaints despite normal SPECT findings.
Methods

Study population
We performed a retrospective analysis of all 11 354 patients who underwent SPECT MPI using 99mTc-Tetrofosmin (Technetium-99m) stress SPECT in the Isala Hospital, in Zwolle, the Netherlands, between January 2009 and December 2014. From this population, 6603 patients (58%) had normal SPECT findings. Subsequent invasive angiogram with FFR measurements within 6 months was performed in 133 patients (=2.0%) with normal SPECT because of persisting or worsening symptoms as expressed during their outpatient follow-up. The persisting complaints consisted of typical or atypical angina or non-anginal chest pain despite the use of medication in optimal doses prescribed by the treating cardiologist. No patients were lost to follow-up. SPECT-scans were considered normal if perfusion was homogeneous throughout the myocardium and the summed stress score was <3. Patients with previous coronary bypass surgery were excluded. The retrospective study was approved by the accredited Committee of Research Ethics of our hospital.
Clinical information
At the time of SPECT examination, all patients completed a questionnaire regarding demographic information, prior medical history, cardiac risk factors, and current medication use. Furthermore, information regarding patient age, gender, weight, height, blood pressure, heart rate, and symptoms were prospectively obtained by a medical nurse.
Diabetes was defined as confirmation of recurrent or persistent hyperglycaemia with glycated haemoglobin > _6.5% (48 mmol/mol) or fasting plasma glucose > _7.0 mmol/L or current use of oral anti-diabetic medication and/or insulin. Hypertension was defined as blood pressure higher than 140/90 mmHg as measured during at least three different times, or use of anti-hypertensive drugs for the indication hypertension. Smoking was defined as current consumption of at least one cigarette, cigar, or pipe daily.
Hypercholesterolaemia was defined as fasting total cholesterol of 5 mmol/L or more, or use of lipid-lowering therapy for the indication hypercholesterolaemia.
SPECT data acquisition
All patients underwent a 1 day stress-only or stress-rest 99mTc-Tetrofosmin SPECT protocol using conventional or cadmium zinc telluride (CZT)-based SPECT. Patients were instructed to refrain from caffeine-containing beverages for at least 24 h before the test. Pharmacologic stress was induced by intravenous administration of adenosine (continuous infusion at a rate of 140 lg/kg/min for 6 min) or dobutamine in case of contra-indication for adenosine (starting with 10 lg/kg/min and increased at 3 min intervals to a maximum of 50 lg/kg/ min until 85% of the predicted heart rate had been reached). Adenosine was used in 95% of patients and dobutamine in 5% of patients. Whenever possible, patients performed additional low-level bicycle exercise to reduce side-effects of adenosine. Electrocardiogram and blood pressure were monitored before, throughout, and following the infusion. A weight-adjusted dose of 99mTc-Tetrofosmin (standard 370 MBq, 500 MBq for patients >100 kg) was injected after 3 min of adenosine infusion. Patients scheduled for rest imaging received a dose of 99mTc-Tetrofosmin (standard 740 MBq, but 1000 MBq for patients >100 kg).
For both, stress and rest SPECT images were acquired 45-60 min after tracer injection.
On the conventional dual-detector gamma camera Ventri (GE Healthcare), images were acquired using a low energy, high-resolution collimator, a 20% symmetrical window at 140 keV, a 64 Â 64 matrix, and an elliptical orbit with step-and-shoot acquisition at 6 intervals over a 180 arc (45 anterior oblique to 45 left posterior oblique) with 30 steps (30 views). All patients were imaged in supine position with arms placed above the head. Acquisition time was 12 min for the stress images and 15 min for the rest images.
The CZT-based SPECT images were acquired using a multi-pinhole camera (Discovery NM/CT 570c, GE Healthcare) and 19 stationary detectors simultaneously imaging the heart. Each detector contained 32 Â 32 pixelated (2.46 Â 2.46 mm) CZT elements. All patients were imaged in supine position with arms placed above the head. Acquisition time was 5 min for the stress images and 4 min for the rest images.
Gated SPECT analysis to calculate left ventricular volumes, ejection fraction, and to assess wall motion abnormalities was done in nearly all patients when feasible, usually at stress but in some cases at rest. Transient ischaemic left ventricular dilatation (TID) was defined as abnormal if the value was >1.36 for adenosine stress. 9 Post-stress left ventricular ejection fraction (LVEF) > _50% for women and > _45% for men was defined as normal LVEF.
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All studies were followed by an unenhanced low-dose computed tomography (CT) scan during a breath-hold to provide the attenuation map for attenuation correction. These scans covered the entire chest with scanning parameters: 5.0-mm slice thickness using a reconstruction algorithm with a 512 Â 512 matrix, and 800 ms rotation times at 120 kV and 20 mA. Emission images as well as attenuation map data were entered in a dedicated reconstruction algorithm to provide 3D volume data (available in a Xeleris workstation, GE Healthcare). These were orientated in the standard way and displayed in the three traditional cardiac axes.
SPECT analysis
All SPECT-scans were analysed by an experienced cardiologist together with an experienced nuclear medicine physician. Segments were scored by consensus of two readers using a 17 segment model for the left ventricle using following five-point scoring system (0, normal; 1, equivocal; 2, moderate; 3, severe reduction in radiotracer uptake; and 4, absence of detectable tracer in a segment). A SPECT was considered normal if the summed stress score was <3. Stress-only SPECT images were considered normal if the summed stress score was <3 and LVEF was normal.
Coronary artery calcium score acquisition and analysis
A non-enhanced CT study was performed for the calcium scoring by using the 64-section CT scanner of the integrated SPECT/CT scanner (LightSpeed VCT XT; GE Healthcare). All patients with heart rates greater than 70 b.p.m. received oral beta-blocker therapy, with 50 or 100 mg of metoprolol tartrate (AstraZeneca, Zoetermeer, the Netherlands) after the pharmacologic stress test and radiotracer injection. Images were obtained with electrocardiographic gating at 75% of the R-R interval and with the following scanning parameters: 40 or 48 sections and 2.5-mm section thickness; gantry rotation time, 330 ms; tube voltage, 120 kV; and a tube current ranging from 125 to 250 mA, depending on patient size. Post-processing was conducted at a dedicated workstation using Smartscore software (GE Healthcare). The total calcium burden in the coronary arteries was manually depicted and allocated to the corresponding coronary artery by an experienced reader using the Agatston method for quantification of the calcium score.
11 Absolute calcium score values and percentile scores were reported without providing any information regarding the interpretation of the calcium scores. All calcium score scans were read by two additional readers, (all with more than 5 years of experience in calcium scoring) at the time of SPECT interpretation. Additionally, for patients without EKG-gated calcium scoring, low-dose attenuation correction scans were used to calculate calcium scores as previously described.
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Invasive angiography and FFR measurements
Invasive coronary angiography was performed with the standard Judkins or radial approach. A 0.014-inch pressure monitoring wire (PressureWire V R ; RADI Medical Systems, Uppsala, Sweden) was set to zero, calibrated, advanced through a guiding catheter, introduced into the coronary artery, and positioned distal to the stenosis under investigation. Adenosine (140 lg/kg/min) was infused continuously to obtain maximal coronary blood flow, corresponding to minimal distal coronary pressure. After maximal hyperaemia had been achieved FFR was calculated as the ratio of the mean distal intracoronary pressure measured by the pressure wire to the mean arterial pressure measured through the coronary guiding catheter. For the purpose of current study, all coronary angiograms were retrospectively re-interpreted visually by two experienced interventional cardiologists.
Classification of coronary artery disease
Coronary stenoses in the right coronary artery (RCA), left circumflex artery (LCX), and left anterior descending (LAD) coronary artery were interpreted as 'functionally relevant obstructive stenoses' if they were both anatomically and functionally relevant as reflected by a luminal narrowing of > _70% together with a FFR value < _0.80. Similarly, left main (LM) stenoses were considered 'functionally relevant obstructive' if the diameter stenosis was > _50% together with a FFR value < _0.80. 10 Patients with concordant significant findings (Group 1: with 'functionally relevant obstructive stenoses') were compared with the patients with concordant non-significant findings or discordant findings (Group 2).
Statistical analysis
Statistical analysis to compare baseline characteristics was performed with the v 2 and one-way analysis of variance as available in SPSS software (version 20 for Windows; SPSS Inc., Chicago, IL, USA). Comparison of continuous data between both groups was performed using the independent samples Student's t-test. Quantitative variables were expressed as mean ± standard deviation and categorical variables as frequencies or percentage. An additional analysis with a FFR threshold of <0.75 was also performed. P-values of less than 0.05 were considered statistically significant.
Results
Baseline characteristics
The mean age of the 133 patients was 64.8 ± 10.4 years, 53 patients (40%) were women, 31 patients (22%) had diabetes. Hypertension, hypercholesterolaemia, and a family history of coronary artery disease were found in more than half of the patients. Twenty-one percent of the patients (n = 28) had a previous percutaneous coronary intervention. Aspirin, beta-blocker, and statin were prescribed to the majority of the patients before they were referred to invasive coronary angiography. In 50% of the patients, the complaints were interpreted as typical angina. The other patients had atypical angina or non-anginal chest pain.
In Table 1 differences in the baseline characteristics between Group 1 (concordant abnormal anatomical and functional findings) as compared with Group 2 (patients with discordant findings or with concordant non-significant findings) are summarized. In short, both groups were comparable, with significantly more nitrate use in patients with true significant abnormalities.
SPECT data acquisition
A total of 129 patients (97%) underwent CZT-based SPECT imaging. A conventional Anger camera was used in the other patients (n = 4). TID was not observed in any of the patients. The prevalence of EKG changes was comparable between the group with both anatomically and functionally relevant stenoses and the rest of the study population (p = 0.58). The majority of the patients (92%) had normal poststress LVEF.
Calcium score
A total of 86 patients (65%) without a history of coronary artery disease underwent simultaneous EKG-gated calcium scoring. In 45 out of the remaining 47 patients, calcium scores were assessed from nongated low-dose attenuation scans. Two patients were scanned without additional calcium scoring or attenuation correction. Overall, the median calcium score was 358 (interquartile range 112-1007 and 0-5022). Calcium scores were comparable between the two groups (see Table 1 ).
FFR measurements
The median interval between SPECT and following angiography was 6 days, interquartile range 1-55 days and 1-190 days). A total of 180 FFR measurements were performed in 133 patients, including 8 measurements of the LM coronary artery, 84 lesions in the LAD, 14 lesions in the diagonal branch, 5 measurements in an anterolateral branch, 35 measurements in the LCX, and 34 measurements in the RCA. At patient level, the majority of patients underwent FFR measurements in the LAD (N = 66, 5%), 29 patients in the LCX (22%), 19 patients in the RCA (14%), 10 patients in the diagonal branch (8%), 5 patients in the anterolateral branch (4%), and 4 patients in the left main (3%).
Concordant and discordant findings at patient level
A total of 34 patients (26%) had anatomically relevant stenoses, whereas 47 patients (35%) had lesions with FFR value < _0.80. Anatomically relevant stenoses with concordant abnormal FFR findings ('functionally relevant obstructive stenoses') were observed in 21 patients (16%), which was 0.3% of the initial population. Anatomically relevant stenosis with discordant FFR findings (FFR >0.80) were found in 13 patients (10%). Of the remaining 99 patients with anatomically non-relevant stenoses and 73 patients (55%) had FFR values >0.80. The distribution of normal and abnormal FFR and significant stenoses are summarized in Table 2 .
Using a FFR cut-off value of <0.75, abnormal FFR results were depicted in 22 patients (17%). Concordant functionally relevant obstructive stenoses with FFR <0.75 were depicted in 10 patients (7, 5%). 
Concordant and discordant findings at vessel level
Overall, a total of 36 lesions (20%) were considered anatomically relevant, while 50 lesions (28%) had an FFR value < _0.80. Anatomically relevant stenoses with concordant abnormal FFR findings ('functionally relevant obstructive stenoses') were observed in 21 lesions (12%). Anatomically relevant stenoses with discordant FFR findings (FFR >0.80) were found in 15 lesions (8.3%). Twentynine lesions (16%) had a FFR < _0.80 without anatomically relevant stenoses. The remaining 115 coronary lesions were non-obstructive with concordant normal FFR findings >0.80 (see Table 2 ). Frequency of both anatomically and functionally relevant stenoses per vessel ('functionally relevant obstructive stenoses') are presented in Figure 1 . Using a FFR cut-off value of <0.75, abnormal FFR results were depicted in 16 lesions (8.9%). Concordant functionally relevant obstructive stenoses with FFR <0.75 were depicted in 8 lesions (4.4%).
Treatment strategy
During follow-up, none of the patients with a FFR value >0.80 underwent coronary revascularization irrespective of anatomical findings. Among the 26 patients with non-relevant anatomical findings but abnormal FFR values, 13 patients (50%) were treated medically, 10 patients (38%) were treated by percutaneous coronary interventions, whereas 3 patients (12%) underwent a CABG. Among the 
patients with concordant abnormal anatomical and FFR findings
('functionally relevant obstructive stenoses') 8 patients (38%) were treated medically, 11 patients (52%) were treated by percutaneous coronary interventions, and the rest (n = 2, 10%) underwent a CABG. Among patients with non-relevant anatomical findings and abnormal FFR values findings, 14 of the 29 lesions were treated medically, whereas 12 lesions were treated by percutaneous coronary intervention and 3 lesions by CABG. Among the lesions with concordant abnormal anatomical and FFR findings ('functionally relevant obstructive stenoses') 13 of the 21 lesions were treated by coronary revascularization (percutaneous coronary intervention in 11 lesions and CABG in 2), whereas 8 patients were treated medically.
Discussion
We found that in this selected population with normal SPECT and persistent complaints, only 16% of the total of 133 study patients had both anatomically and functionally relevant stenoses. Interestingly, in our population significant left main disease was present in only 1 patient (0.8%). Our findings suggest that the prevalence of false-negative SPECT findings in patients with persistent complaints is low and occurrence of balanced ischaemia is infrequent.
Current guidelines recommend non-invasive testing as initial diagnostic strategy in patients with suspected stable coronary artery disease, particularly in patients with an intermediate pre-test probability for obstructive coronary disease. 13 Several studies have shown only improved clinical outcome after revascularization in patients with proven functionally relevant coronary artery disease based on functional testing, while coronary interventions can be safely deferred in patients without ischaemia. [14] [15] [16] [17] However, despite guidelines and recommendations approximately half of the patients referred to elective coronary revascularization have no objective proof of ischaemia. [18] [19] [20] Stress SPECT can serve as a gatekeeper, accurately identifying lowrisk patients, and appropriately directing the use of invasive procedures. Invasive coronary angiography is recommended in patients with severe stable angina or with a high-risk profile based on clinical profile or non-invasive testing, and should be considered in patients with an inconclusive diagnosis or conflicting results from different imaging modalities. Under such circumstances, the indication for revascularization should depend on the result of intra-procedural FFR testing when indicated. 13 Discrepancies between FFR and SPECT imaging have been described in 10-40%. 21 Various explanations for such discordant findings have been suggested including false-negative SPECT or falsepositive FFR results. False-negative SPECT may be due to inadequate vasodilatation during stress, for example due to recent caffeine intake in adenosine stress or inadequate exercise in a physical stress test. But also FFR, which is increasingly considered the new gold standard, can result in incorrect diagnoses. Reasons may be insufficient hyperaemia, guiding catheter related pitfall, electrical drift, diffuse disease rather than focal stenosis, small perfusion territory, severe microvascular disease, abundant collaterals, and severe left ventricular hypertrophy. [22] [23] [24] Importantly, it should be emphasized again that FFR was initially validated against non-invasive tests including thallium SPECT imaging in which discordant results were also reported in 22% of the patients. 25 The implementation of a cut-off value of < _0.80
has been proven valid from prognostic point of view, [15] [16] [17] however, using FFR <0.75 for demonstrating true ischaemia as suggested in the validation studies may be more appropriate. 25 In our study, the frequency of functionally relevant stenoses was only 7.5% using a threshold of <0.75. In patients with normal non-invasive functional test results, other causes for their complaints should be considered. When symptoms do not improve despite a trial of optimal medical treatment, further Abnormal FFR following normal SPECT intensification of medical treatment is recommended. In case of persistent complaints despite optimal medical treatment, invasive angiography with FFR measurement should be considered. 13 However, Lachance et al., 26 demonstrated that additional invasive FFR measurement had the greatest impact in the evaluation of lesions with documented ischaemia on non-invasive tests, while the FFR measurement had little impact in case of a non-ischaemic test result. In addition, the invasive nature of FFR measurement accompanies a non-negligible risk with incremental procedure time. Alternatively, non-invasive CT coronary angiography could be used to exclude the presence of obstructive coronary artery disease following a normal SPECT scan in patients with persistent complaints. 27 Although invasive coronary angiography is not routinely performed after normal SPECT, these scans can be falsely negative and, in a patient with high pre-test likelihood of coronary disease. Bayes' theorem predicts that a high posttest likelihood of coronary artery disease will remain as well. Our study demonstrated a low frequency of obstructive coronary stenoses that were both anatomically and functionally relevant. This may, in part, reflect the overestimation of obstructive coronary disease as assessed using current pre-test probabilities.
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Limitations
There are several limitations of our study. First, we studied a highly selected group of patients, with all persistent complaints after normal SPECT. Second, several data were retrospectively collected. Third, we did neither perform other functional tests such as positron emission tomography imaging, cardiac magnetic resonance perfusion imaging, nor coronary flow reserve measurements in our patients. Fourth, we used data from a high-volume centre (2000 SPECT procedures annually), and therefore, our findings must be read with caution before extrapolating to different centres. Fifth, we did not compare baseline characteristics of our current cohort with those of the patients without persisting symptoms. Sixth, the number of patients with relevant stenoses was low, and therefore, the study was underpowered to show potential differences between patients with and without relevant stenoses. Finally, we did not collect additional follow-up data on symptom status in our population.
Conclusion
In selected patients with normal SPECT and persistent anginal complaints, the prevalence of functionally relevant coronary artery disease as defined by concordant abnormal angiography and FFR is (very) low. A 70-year-old female patient visited our hospital with atypical chest discomfort. Physical examination revealed ejection systolic murmur. The chest X-ray showed an increased cardiac shadow (Panel A). Transthoracic echocardiography (TTE) in the parasternal short-axis view at the level of the aortic valve showed systolic doming of pulmonary valve leaflets and a dilated pulmonary artery (Panel B, arrowhead).
Continuous wave Doppler at the pulmonary valve showed mild pulmonary stenosis. Cardiac magnetic resonance (CMR) images and multidetector computed tomography (MDCT) distinctly revealed a quadricuspid pulmonary valve (QPV) with three equal-sized cusps and a hypoplastic cusp (the Hurwitz and Roberts classification Type B), and a dilated pulmonary artery (Panels C-E, Supplementary data online, Movie S1). Re-evaluation with TTE by a short-axis view of the pulmonary valve in a higher intercostal window enabled visualization of a QPV (Panel F, Supplementary data online, Movie S2). QPV is a rare congenital heart disease and associations with other structural cardiovascular malformations have been reported, such as atrial or ventricular septal defects, aortic valve abnormalities, and patent ductus arteriosus. QPV is categorized according to the Hurwitz and Roberts classification that recognized seven Types (A-G); MDCT and CMRI are highly useful for the classification as well as diagnosis. Diagnosis of a QPV by TTE is difficult due to the anatomical disposition of the pulmonary valve, however, evaluation in a higher intercostal window may be helpful. Development of multi-modal imaging contributes to diagnosis and visualization of morphological valvular features of QPV in living patients.
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
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